Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
BMJ Case Rep ; 14(4)2021 Apr 26.
Article in English | MEDLINE | ID: covidwho-1203957

ABSTRACT

This is a case report of a middle-aged man with no psychiatric history who presented with severe anxiety and psychotic symptoms from COVID-19. Following his discharge from intensive care unit, he was unable to sleep, was increasingly agitated and was observed hitting his head off the walls, causing haematomas. He remained highly anxious and developed paranoid delusions and auditory and tactile hallucinations, needing admission to a psychiatric ward. Treatment with antipsychotic medication gradually improved his symptoms in a few weeks. This case report highlights the new onset of psychosis due to COVID-19 infection. It demonstrates the importance of early identification and treatment of neuropsychiatric complications within an acute hospital setting. Furthermore, there is a need for research in this area to help in the prevention and treatment of such psychiatric complications due to COVID-19.


Subject(s)
COVID-19/complications , Delusions/etiology , Psychotic Disorders/etiology , Antipsychotic Agents/therapeutic use , COVID-19/psychology , Delusions/drug therapy , Humans , Male , Middle Aged , Psychotic Disorders/drug therapy , SARS-CoV-2 , Treatment Outcome
2.
Psychiatriki ; 32(1): 79-82, 2021 Apr 19.
Article in English | MEDLINE | ID: covidwho-1148406

ABSTRACT

The COVID-19 outbreak has affected millions of people globally and it also has a huge psychological impact. The objective of this case report is to outline the possible effect of the COVID-19 pandemic to the content of delusions in patients with psychosis. Α 34-year-old male with no history of mental disorder, involuntarily hospitalized due to agitation and aggression towards others, experienced grandiose delusions, referential delusions and delusions of passivity. The content of all his delusions was related to the COVID-19 pandemic. His symptoms were not proven to be caused by any physical condition or substance use disorder. He was prescribed olanzapine 10mg bd and lorazepam 2,5mg td and demonstrated significant improvement with a complete subsidence of his symptoms within a week. He was discharged after a total of 13 days with an ICD-10 diagnosis of brief psychotic disorder. At his 6 months follow-up, he reported no psychiatric symptoms. Existing literature indicates a strong relationship between life experiences and the content of delusions. This case report highlights how the stressful life event of the COVID-19 outbreak affected the content of our patient's delusions.


Subject(s)
COVID-19/psychology , Delusions/psychology , Pandemics , Psychotic Disorders/psychology , Adult , Aggression , Anti-Anxiety Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Delusions/drug therapy , Humans , Involuntary Commitment , Life Change Events , Lorazepam/therapeutic use , Male , Olanzapine/therapeutic use , Psychomotor Agitation , Psychotic Disorders/drug therapy , Stress, Psychological/complications , Stress, Psychological/psychology
3.
Schizophr Bull ; 47(1): 15-22, 2021 01 23.
Article in English | MEDLINE | ID: covidwho-1045828

ABSTRACT

The impact of the COVID-19 pandemic on psychosis remains to be established. Here we report 6 cases (3 male and 3 female) of first-episode psychosis (FEP) admitted to our hospital in the second month of national lockdown. All patients underwent routine laboratory tests and a standardized assessment of psychopathology. Hospitalization was required due to the severity of behavioral abnormalities in the context of a full-blown psychosis (the Brief Psychiatric Rating Scale [BPRS] = 75.8 ± 14.6). Blood tests, toxicological urine screening, and brain imaging were unremarkable, with the exception of a mild cortical atrophy in the eldest patient (male, 73 years). All patients were negative for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout their stay, but 3 presented the somatic delusion of being infected. Of note, all 6 cases had religious/spiritual delusions and hallucinatory contents. Despite a generally advanced age (53.3 ± 15.6), all patients had a negative psychiatric history. Rapid discharge (length of stay = 13.8 ± 6.9) with remission of symptoms (BPRS = 27.5 ± 3.1) and satisfactory insight were possible after relatively low-dose antipsychotic treatment (Olanzapine-equivalents = 10.1 ± 5.1 mg). Brief psychotic disorder/acute and transient psychotic disorder diagnoses were confirmed during follow-up visits in all 6 cases. The youngest patient (female, 23 years) also satisfied the available criteria for brief limited intermittent psychotic symptoms. Although research on larger populations is necessary, our preliminary observation suggests that intense psychosocial stress associated with a novel, potentially fatal disease and national lockdown restrictions might be a trigger for FEP.


Subject(s)
COVID-19/prevention & control , Communicable Disease Control , Delusions , Hallucinations , Psychotic Disorders , Stress, Psychological/complications , Adult , Aged , Antipsychotic Agents/administration & dosage , Delusions/diagnosis , Delusions/drug therapy , Delusions/etiology , Female , Follow-Up Studies , Hallucinations/diagnosis , Hallucinations/drug therapy , Hallucinations/etiology , Humans , Italy , Male , Middle Aged , Psychotic Disorders/diagnosis , Psychotic Disorders/drug therapy , Psychotic Disorders/etiology , Remission Induction , Time Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL